Andrew Dorr
Impact in
Papers in
- Oncology 13
- Cancer Treatment and Pharmacology 4
- PARP inhibition in cancer therapy 4
-
- Protein Kinase Regulation and GTPase Signaling 3
- Melanoma and MAPK Pathways 3
- 14-3-3 protein interactions 2
- Co-authors
- Richard S. Geary (7 shared papers)Jon Holmlund (7 shared papers)T. Jesse Kwoh (4 shared papers)John Nemunaitis (3 shared papers)Branimir I. Šikić (3 shared papers)Casey Cunningham (2 shared papers)Joanne Halsey (2 shared papers)George A. Fisher (2 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Cancer Research (4 papers)Lung Cancer (2 papers)Cancer (2 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Andrew Dorr
36 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 70
- Oncology 312
- Genetics 116
- Molecular Biology 662
- Hematology 95
- Cancer Research 74
Countries citing papers authored by Andrew Dorr
This map shows the geographic impact of Andrew Dorr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Dorr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Dorr more than expected).
Fields of papers citing papers by Andrew Dorr
This network shows the impact of papers produced by Andrew Dorr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Dorr. The network helps show where Andrew Dorr may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Dorr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 141 | |
| 2 | Phase I study of an antisense oligonucleotide to protein kinase C-alpha (ISIS 3521/CGP 64128A) in patients with cancer. | 1999 | 121 |
| 3 | A phase I trial of c-Raf kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer. | 2000 | 108 |
| 4 | A randomized phase II and pharmacokinetic study of the antisense oligonucleotides ISIS 3521 and ISIS 5132 in patients with hormone-refractory prostate cancer. | 2002 | 99 |
| 5 | 2015 | 97 | |
| 6 | 2001 | 71 | |
| 7 | 2013 | 62 | |
| 8 | 2004 | 56 | |
| 9 | 2003 | 55 | |
| 10 | 2003 | 44 | |
| 11 | 1994 | 36 | |
| 12 | 2023 | 21 | |
| 13 | 2009 | 21 | |
| 14 | The role of laparoscopic hysterectomy and lymph node dissection in treatment of endometrial cancer. | 1999 | 18 |
| 15 | 2003 | 17 | |
| 16 | 2020 | 17 | |
| 17 | 2022 | 12 | |
| 18 | 2013 | 9 | |
| 19 | 2021 | 9 | |
| 20 | 2020 | 7 |
About Andrew Dorr
Andrew Dorr is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 38 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), PARP inhibition in cancer therapy (4 papers), Prostate Cancer Treatment and Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Melanoma and MAPK Pathways (3 papers), 14-3-3 protein interactions (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). The work is most often cited by research in Oncology (312 citations), Genetics (116 citations), Molecular Biology (662 citations), Hematology (95 citations) and Cancer Research (74 citations). Andrew Dorr has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Richard S. Geary, Jon Holmlund, T. Jesse Kwoh, John Nemunaitis, Branimir I. Šikić, Casey Cunningham, Joanne Halsey, George A. Fisher, Elizabeth A. Eisenhauer and Joan H. Schiller. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Lung Cancer, Cancer and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.